Prelude Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.3K | Buy |
+22,133
| New | +$94.3K | 0.01% | 916 |
|
|
2024
Q2 | – | Sell |
-32,700
| Closed | -$370K | – | 1315 |
|
|
2024
Q1 | $370K | Buy |
+32,700
| New | +$370K | 0.02% | 700 |
|
|
2023
Q2 | – | Sell |
-16,225
| Closed | -$56.3K | – | 1184 |
|
|
2023
Q1 | $56.3K | Sell |
16,225
-3,726
| -19% | -$12.9K | ﹤0.01% | 901 |
|
|
2022
Q4 | $48.9K | Buy |
19,951
+1,200
| +6% | +$2.94K | ﹤0.01% | 990 |
|
|
2022
Q3 | $52K | Sell |
18,751
-9,256
| -33% | -$25.7K | ﹤0.01% | 1185 |
|
|
2022
Q2 | $114K | Buy |
28,007
+13,719
| +96% | +$55.8K | ﹤0.01% | 1188 |
|
|
2022
Q1 | $61K | Buy |
+14,288
| New | +$61K | ﹤0.01% | 1182 |
|